Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by DaveInCalgaryon Aug 16, 2023 6:59pm
149 Views
Post# 35591964

RE:Future earnings

RE:Future earningsThe German ministry of Health Bill, to remove the narcotics classification from medical cannabis on Jan 1, 2024 will have a huge impact on Sales since Germany will be allowing "Anyone who needs #Cannabis as #Medizin should get it.
That's why we've made it easier to prescribe medicinal cannabis!
We are shortening the reservation of approval, instructing the GBA to define specialist groups in which the reservation of approval is completely eliminated."
Some experts are predicting 4X larger market than Florida = $12B/year.

3rd Quarter from Dec 1, 2023 thru Feb 28, 2024 will likely be the largest upcoming growth.
Say German medical distribution & cannabis sales double YOY with this Descheduling.
Newly added operating breweries come online after 90 days (mid Nov. 2023) which will likely triple beverage sales compared to 3rd Quarter 22/23.
(Montauk added Nov 22)
Plenty of growth and more coming

 
<< Previous
Bullboard Posts
Next >>